SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--Today at the Advances in Genome Biology and Technology (AGBT) Conference, DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on ...
SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a leader in Enzymatic DNA Synthesis (EDS), announced the CE marking of its SYNTAX System, the first EDS-powered benchtop DNA printer.
The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster SOUTH SAN FRANCISCO, Calif., and PARIS, May 20, 2021 /PRNewswire/ -- DNA Script, a leading pioneer in ...
DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has reached a distribution agreement with Premas Life Sciences Pvt. Ltd., India, a leading biotechnology distribution ...
DNA Script SAS is closing a $200 million series C fundraising round, with new investors pumping in cash to push commercialization of its DNA printing platform Syntax. The company has raised a total of ...
Following the launch of its benchtop DNA printer earlier this year, DNA Script has secured a hefty $165 million to take its platform to the masses. The nine-digit proceeds represent a big leap in DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback